| abstract |
The present invention provides a compound of formula (I): [where variables are defined herein] or a pharmaceutically acceptable salt thereof, which is useful as a JAK kinase inhibitor. The present invention also provides pharmaceutical compositions containing such compounds, and methods of using such compounds to treat respiratory diseases. The invention also provides a method of treating respiratory diseases, especially asthma and CLAD, in a mammal, the method comprising administering to the mammal a therapeutically effective amount of a compound or pharmaceutical composition of the invention. .. |